IPO
Polyphor AG shareholders approved all motions put forward by the Board of Directors to the 22nd Annual General Meeting in Basel.
The shareholders in Recipharm AB (publ), reg. no. 556498-8425, are hereby invited to attend the Annual General Meeting (“AGM”) to be held on Monday 13 May 2019 at 3.00 pm at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden.
The new accounting standard, IFRS 16 will have an estimated positive impact on EBITDA of SEK 90 million in 2019.
Heidelberg Pharma AG reported on the first three months of fiscal year 2019 (1 December 2018 - 28 February 2019) and the Group’s financial figures.
Pharming Group N.V. announces that the Notice to Convene for its Annual General Meeting of Shareholders has been uploaded on its website.
The shareholders in BioArctic AB, corporate identity number 556601-2679 are hereby summoned to the Annual General Meeting to be held on May 9, 2019, at 5 p.m., at Grant Thornton Sweden AB’s offices, Sveavägen 20, Stockholm, Sweden.
MorphoSys AG announced that it has published its agenda for the Company’s ordinary Annual General Meeting, which will take place on Wednesday, May 22, 2019.
Galapagos NV announced that its board of directors created 2,070,000 warrants under new warrant plans for the benefit of the employees, directors, and a consultant of the company and its subsidiaries.
Pharming has acquired its shareholding through the conversion of €2.5 million of existing credits and €1.6 million of new cash subscription for a total of €4.1 million in BioConnection shares, plus additional shares acquired from existing investors.
A summary of IPOs from companies in the biotech and pharma world since April 1, 2019.
PRESS RELEASES